Iron misregulation in the brain: a primary cause of neurodegenerative disorders

被引:303
作者
Ke, Y
Qian, ZM [1 ]
机构
[1] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Lab Brain Iron Metab, Kowloon, Hong Kong, Peoples R China
[2] Hebei Normal Univ, Inst Neurobiol & Neuropharmacol, Shijiazhuang, Hebei Province, Peoples R China
关键词
D O I
10.1016/S1474-4422(03)00353-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
High iron concentrations in the brains of patients and the discovery of mutations in the genes associated with iron metabolism in the brain suggest that iron misregulation in the brain plays a part in neuronal death in some neuro-degenerative disorders, such as Alzheimer's, Parkinson's, and Huntington's diseases and Hallervorden-Spatz syndrome. Iron misregulation in the brain may have genetic and non-genetic causes. The disrupted expression or function of proteins involved in iron metabolism increases the concentration of iron in the brain. Disturbances can happen at any of several stages in iron metabolism (including uptake and release, storage, intracellular metabolism, and regulation). Increased brain iron triggers a cascade of deleterious events that lead to neurodegeneration. An understanding of the process of iron reglation in the brain, the proteins important in this process, and the effects of iron misregulation could help to treat or prevent neurodegenerative disrders.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 104 条
[1]   Iron homeostasis: Insights from genetics and animal models [J].
Andrews, NC .
NATURE REVIEWS GENETICS, 2000, 1 (03) :208-217
[2]   Medical progress: Disorders of iron metabolism [J].
Andrews, NC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1986-1995
[3]  
Andrews NC, 1999, NUTR REV, V57, P114, DOI 10.1111/j.1753-4887.1999.tb06934.x
[4]   HALLERVORDEN-SPATZ DISEASE - CLINICAL AND MRI STUDY OF 11 CASES DIAGNOSED IN LIFE [J].
ANGELINI, L ;
NARDOCCI, N ;
RUMI, V ;
ZORZI, C ;
STRADA, L ;
SAVOIARDO, M .
JOURNAL OF NEUROLOGY, 1992, 239 (08) :417-425
[5]   Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism [J].
Attieh, ZK ;
Mukhopadhyay, CK ;
Seshadri, V ;
Tripoulas, NA ;
Fox, PL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) :1116-1123
[6]   Brain iron pathways and their relevance to Parkinson's disease [J].
Berg, D ;
Gerlach, M ;
Youdim, MBH ;
Double, KL ;
Zecca, L ;
Riederer, P ;
Becker, G .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (02) :225-236
[7]   Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease [J].
Boll, MC ;
Sotelo, J ;
Otero, E ;
Alcaraz-Zubeldia, M ;
Rios, C .
NEUROSCIENCE LETTERS, 1999, 265 (03) :155-158
[8]   An update on Iron Metabolism: Summary of the Fifth International Conference on Disorders of Iron Metabolism [J].
Bonkovsky, HL ;
Ponka, P ;
Bacon, BR ;
Drysdale, J ;
Grace, ND ;
Tavill, AS .
HEPATOLOGY, 1996, 24 (03) :718-729
[9]  
BRITTENHAM GM, 2000, HEMATOLOGY, V1, P39
[10]   The iron regulatory proteins: Targets and modulators of free radical reactions and oxidative damage [J].
Cairo, G ;
Recalcati, S ;
Pietrangelo, A ;
Minotti, G .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (12) :1237-1243